Doceree – a leading global network of physician-only platforms for programmatic messaging – recently announced a $35 million Series B round led by Creaegis, the leading digital and technology investment firm. Existing investors Eight Roads Ventures and F-Prime Capital also joined the round.
Driven by a global mission to transform healthcare professional (HCP) marketing, the funds will enable Doceree to accelerate product development, augment technologies, scale global expansion, and expand its team.
Launched in 2019, Doceree empowers pharmaceutical and life-sciences companies and healthcare media agencies with solutions that seamlessly reach HCPs on their networks and within their digital workflows to achieve better patient health outcomes. With its global network of HCP-only digital platforms, the company has made strides in HCP communications through its programmatic messaging capabilities to help clients across the globe maximize the performance of their physician engagement initiatives.
Doceree has grown over 100% in the last year, with monthly revenue rising fivefold between the Series A funding in April 2022 and now. The company also introduced category-first innovations on the demand and supply sides, including Doceree Enterprise, an HCP-focussed global Demand Side Platform (DSP), and Doceree Provider, which empowers HCPs to improve the health outcomes of the patients. The HCP marketing ecosystem consists of custom-built solutions that equip life science marketers to engage with physicians at opportune moments with contextual messaging and evaluate campaign performances to improve script lift.
With the huge response to its solutions in the US, India, and the European markets, Doceree expanded its footprints to Africa, Southeast Asia (SEA), and the Gulf Cooperation Council (GCC) – curating solutions that serve the specific needs of marketers in these regions.
KEY QUOTES:
“We are pioneering HCP messaging solutions that are first to market. It is incredible to watch our innovative products disrupt the space and drive adoption of programmatic technology in the life-sciences industry, not just in evolved markets like the US, but also elsewhere in the same vein. We have been able to simplify HCP engagement globally with our unique AI-enabled proprietary technology and offer quality end-to-end HCP-targeting solutions that have helped our clients succeed with profitable growth. The pharma messaging space is evolving at a fast pace and our solutions are aligned to meet the immediate requirements of the life sciences industry. The investment speaks volumes about the value we are creating in the space. We are growing massively and have competitive edge. We are thrilled about the future as we continue to expand and touch new horizons in the space.”
— Harshit Jain MD, Founder & Global CEO, Doceree
“We are excited to partner with Harshit and the Doceree team to support the company in its next phase of growth led by an industry leading digital platform driven by deep learning-based data models. Our past experience of investing in pioneering global SaaS companies and in the healthcare ecosystem will enable us to support the company’s mission to create superior outcomes for pharma brands, providers and patients.”
— Prakash Parthasarathy, Managing Partner & CIO and Nitish Bandi, Partner, Creaegis
“Doceree’s technology platform allows biopharmaceutical companies to connect with physicians like never before. The company’s impressive growth trajectory is an outcome of its unique, data-driven approach to enable communication with precision and relevance. It has been exciting to partner with Harshit and the team since their Series A round, and we are thrilled to continue supporting their pioneering work.”
— Ashish Venkataramani, Partner, Eight Roads Ventures
